Key Market Indicators
Sales of Swiss digestive system disorder medicines are projected to reach $1.13 billion by 2026, up from $1.04 billion in 2021. On average, the market has grown 2.2% each year since 1992. In 2021, the United Kingdom led the market with $1.04 billion, followed by Japan, South Korea and Canada at $1.03 billion, $0.87 billion and $0.85 billion respectively.